-
平臺編號：bio-68828
-
國際編號：HB-8693?
-
細胞信息： UCD/AB 6.01
-
規(guī)格：frozen
-
用途：ATCC原裝細胞
-
服務(wù)費用：
加載中…… - 訂購
-
注意事項：僅用于科學研究或者工業(yè)應用等非醫(yī)療目的不可用于人類或動物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準）
UCD/AB 6.01
是否是腫瘤細胞：0
物種來源：小鼠
生長狀態(tài)：懸浮生長
運輸方式：凍存運輸
細胞形態(tài)：淋巴樣
ATCC Number：HB-8693?
數(shù)量：大量
規(guī)格：0.5ml Designations: UCD/AB 6.01
Depositors: ?Regents of the University of California
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Mus musculus (B cell); Mus musculus (myeloma) deposited as mouse (B cell); mouse (myeloma)
Morphology:lymphoblast
Source: Cell Type: hybridoma: B lymphocyte;
Cellular Products:immunoglobulin; monoclonal antibody; against a human mammary carcinoma cell line (MCF7, see ATCC HTB-22 )
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Comments:Animals were immunized with the MCF7 human mammary cancer cell line.
Spleen cells were fused with P3X63Ag8.653 myeloma cells.
The antibody is specific for type 8 cytokeratin (52000 dalton).
It cross-reacts somewhat with types 18 and 19 cytokeratins (46000 dalton and 40000 dalton, respectively).
The antibody can be used to detect cytokeratin released by neoplastic cells into serum.
Propagation: ATCC complete growth medium: RPMI 1640 medium with non-essential amino acids, 90%; fetal bovine serum, 10%
Subculturing: Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.
Preservation: culture medium, 90%; DMSO, 10%
References: 3931: Cardiff RD, et al. Cytokeratin tumor markers and assays for their detection. US Patent 4,775,620 dated Oct 4 1988
物種來源：小鼠
生長狀態(tài)：懸浮生長
運輸方式：凍存運輸
細胞形態(tài)：淋巴樣
ATCC Number：HB-8693?
數(shù)量：大量
規(guī)格：0.5ml Designations: UCD/AB 6.01
Depositors: ?Regents of the University of California
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Mus musculus (B cell); Mus musculus (myeloma) deposited as mouse (B cell); mouse (myeloma)
Morphology:lymphoblast
Source: Cell Type: hybridoma: B lymphocyte;
Cellular Products:immunoglobulin; monoclonal antibody; against a human mammary carcinoma cell line (MCF7, see ATCC HTB-22 )
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Comments:Animals were immunized with the MCF7 human mammary cancer cell line.
Spleen cells were fused with P3X63Ag8.653 myeloma cells.
The antibody is specific for type 8 cytokeratin (52000 dalton).
It cross-reacts somewhat with types 18 and 19 cytokeratins (46000 dalton and 40000 dalton, respectively).
The antibody can be used to detect cytokeratin released by neoplastic cells into serum.
Propagation: ATCC complete growth medium: RPMI 1640 medium with non-essential amino acids, 90%; fetal bovine serum, 10%
Subculturing: Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.
Preservation: culture medium, 90%; DMSO, 10%
References: 3931: Cardiff RD, et al. Cytokeratin tumor markers and assays for their detection. US Patent 4,775,620 dated Oct 4 1988
